Cyabra, Inc. Operating Cash Flow
Cyabra, Inc. (CYAB) reported Operating Cash Flow of -$5.00 million for the 6-month period ending 2026-06-30, per its S-1/A filed 2026-09-16.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-09-16
- Cyabra, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$2.40M.
- Cyabra, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$2.60M.
- Cyabra, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-06-30 was -$2.56M.
- Cyabra, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-03-31 was -$1.27M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|
| 2026-06-30 | -$2.40M derived: S-1/A 6 month − S-1 3 month · filed 2026-09-16 | -$5.00M S-1/A · filed 2026-09-16 | |
| 2026-03-31 | -$2.60M S-1 · filed 2026-07-31 | ||
| 2025-12-31 | -$8.14M S-1/A · filed 2026-09-16 | ||
| 2025-06-30 | -$2.56M derived: S-1/A 6 month − S-1 3 month · filed 2026-09-16 | -$3.83M S-1/A · filed 2026-09-16 | |
| 2025-03-31 | -$1.27M S-1 · filed 2026-07-31 | ||
| 2024-12-31 | -$5.20M S-1/A · filed 2026-09-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Iveda Solutions, Inc. (IVDA) | United States | $0.004B | |
| BIO KEY INTERNATIONAL INC (BKYI) | United States | $0.003B | |
| GAXOS.AI INC. (GXAI) | United States | $0.006B | -3.26 |
| Amesite Inc. (AMST) | United States | $0.007B | -2.79 |
| Zedge, Inc. (ZDGE) | United States | $0.002B | 0.43 |
| authID Inc. (AUID) | United States | $0.007B | |
| My Size, Inc. (MYSZ) | $0.001B | ||
| zSpace, Inc. (ZSPC) | United States | $0.009B | |
| FingerMotion, Inc. (FNGR) | Singapore | $0.009B | -6.67 |
| AppTech Payments Corp. (APCX) | United States | $0.010B |